A carregar...
The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
The development of novel regulatory tools such as adaptive clinical trial design and utilization of real-world evidence are topics of high interest. Recently, the European Medicines Agency (EMA) introduced the Adaptive Pathways (AP) that represents an innovative tool in healthcare systems allowing t...
Na minha lista:
| Publicado no: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6610487/ https://ncbi.nlm.nih.gov/pubmed/31316991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00148 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|